ABAT: Difference between revisions
Jump to navigation
Jump to search
m (Bot: HTTP→HTTPS) |
m (task, replaced: PloS One → PLOS One (2), removed stub tag) |
||
| Line 1: | Line 1: | ||
{{Infobox_gene}} | {{Infobox_gene}} | ||
'''4-Aminobutyrate aminotransferase''' is a [[protein]] that in humans is encoded by the ABAT [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: 4-aminobutyrate aminotransferase | url = https://www.ncbi.nlm.nih.gov/gene/18 }}</ref> | '''4-Aminobutyrate aminotransferase''' is a [[protein]] that in humans is encoded by the ABAT [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: 4-aminobutyrate aminotransferase | url = https://www.ncbi.nlm.nih.gov/gene/18 }}</ref> This gene is located in chromosome 16 at position of 13.2.<ref name=":0">{{cite journal | vauthors = Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H | title = GABA and GABA receptors in the central nervous system and other organs | journal = International Review of Cytology | volume = 213 | pages = 1–47 | date = 2002 | pmid = 11837891 | doi = 10.1016/s0074-7696(02)13011-7 | publisher = Elsevier | isbn = 9780123646170 }}</ref> This gene has also different name, to give some are [[Gamma-Aminobutyric acid|GABA]], GABAT, [[4-aminobutyrate transaminase]], NPD009 and etc.<ref name=":0" /> This gene is mainly and abundant located in [[Nervous tissue|neuronal tissues]].<ref name=":1">{{cite journal | vauthors = Jirholt J, Asling B, Hammond P, Davidson G, Knutsson M, Walentinsson A, Jensen JM, Lehmann A, Agreus L, Lagerström-Fermer M | title = 4-aminobutyrate aminotransferase (ABAT): genetic and pharmacological evidence for an involvement in gastro esophageal reflux disease | journal = PLOS One | volume = 6 | issue = 4 | pages = e19095 | date = April 2011 | pmid = 21552517 | pmc = 3084265 | doi = 10.1371/journal.pone.0019095 }}</ref> 4-Aminobutyrate aminotransferase belongs to group of pyridoxal 5-phosphate-dependent enzyme which activates a large portion giving reaction to amino acids.<ref>{{cite journal | vauthors = Markova M, Peneff C, Hewlins MJ, Schirmer T, John RA | title = Determinants of substrate specificity in omega-aminotransferases | journal = The Journal of Biological Chemistry | volume = 280 | issue = 43 | pages = 36409–16 | date = October 2005 | pmid = 16096275 | doi = 10.1074/jbc.m506977200 }}</ref> ABAT is made up of two monomers of enzymes where each subunit has a molecular weight of 50kDa.<ref>{{cite journal | vauthors = Churchich JE | title = 4-Aminobutyrate aminotransferase. Different susceptibility to inhibitors, microenvironment of the cofactor binding site and distance of the catalytic sites | journal = European Journal of Biochemistry | volume = 126 | issue = 3 | pages = 507–11 | date = September 1982 | pmid = 7140743 }}</ref> It is identified that almost tierce of human synapses have GABA.<ref name=":0" /> [[Gamma-Aminobutyric acid|GABA]] is a [[neurotransmitter]] that has different roles in different regiions of the central and peripheral nervous systems. It can be found also in some tissues that do not have neurons.<ref name=":0"/> In addition, GAD and [[GABAA receptor|GABA-AT]] are responsible in regulating the concentration of GABA.<ref name=":2">{{cite journal | vauthors = Tovar-Gudiño E, Guevara-Salazar JA, Bahena-Herrera JR, Trujillo-Ferrara JG, Martínez-Campos Z, Razo-Hernández RS, Santiago Á, Pastor N, Fernández-Zertuche M | title = Pseudomonas fluorescens and In Silico Molecular Modeling | journal = Molecules | volume = 23 | issue = 5 | pages = 1128 | date = May 2018 | pmid = 29747438 | doi = 10.3390/molecules23051128 }}</ref> | ||
== Characteristic == | |||
GABA’s feature is that it does not fluorescent nor electroactive which is why it is hard to determine the reaction of enzymes because no peroxidase and dehydrogenase was identified.<ref name=":3">{{cite journal | vauthors = Salazar-Sánchez JC, Morales-Villagrán A, López-Pérez SJ, Pardo-Peña K, Villalpando-Vargas F, Medina-Ceja L | title = γ-Aminobutyric acid quantification in small volume biological samples through enzymatically induced electrochemiluminescence | journal = Luminescence | volume = 33 | issue = 4 | pages = 722–730 | date = June 2018 | pmid = 29653023 | doi = 10.1002/bio.3469 }}</ref> One characteristic of GABA is having low lipophilic which results in the difficulty to cross the blood brain barrier. A lot of researchers have been trying to discover molecules that have a property of high lipophilicity.<ref name=":2" /> The quantification of GABA concentration during cell activity needs to have high spatial and temporal resolution. As before, high performance liquid chromatography ([[High-performance liquid chromatography|HPLC]]) was used in quantifying GABA concentration levels. In present time, GABA is now analyze, measured in small volume with a short period of time with the use of electrochemiluminescence.<ref name=":3" /> GABA acts as a tropic factor which then affects some cell activity such as rapid cell reproduction, cell death and differentiation. Intracellular communication is also one of the many functions of GABA outside the nervous system.<ref name=":3" /> | |||
== Function == | == Function == | ||
4-Aminobutyrate aminotransferase (ABAT) is responsible for [[catabolism]] of [[gamma-aminobutyric acid]] (GABA), an important, mostly inhibitory [[neurotransmitter]] in the [[central nervous system]], into [[succinic semialdehyde]]. The active enzyme is a [[homodimer]] of 50-kD subunits complexed to [[pyridoxal phosphate|pyridoxal-5-phosphate]]. The protein sequence is over 95% similar to the pig protein | 4-Aminobutyrate aminotransferase (ABAT) is responsible for [[catabolism]] of [[gamma-aminobutyric acid]] (GABA), an important, mostly inhibitory [[neurotransmitter]] in the [[central nervous system]], into [[succinic semialdehyde]]. The active enzyme is a [[homodimer]] of 50-kD subunits complexed to [[pyridoxal phosphate|pyridoxal-5-phosphate]]. The protein sequence is over 95% similar to the pig protein. ABAT in liver and brain is controlled by 2 codominant alleles with a frequency in a Caucasian population of 0.56 and 0.44.<ref name="entrez" /> GABA acts as a tropic factor which then affects some cell activity such as rapid cell reproduction, cell death and differentiation. Intracellular communication is also one of the many functions of GABA outside the nervous system.<ref name=":3" /> GABA-transaminaze enzyme production was made of ABAT gene command. The main function of ABAT acts as inhibition (neurotransmitter), where it prevents overloading activity of the brain from large amount of signals.<ref name=":0" /> | ||
ABAT activates the beginning of deterioration of GABA. Likewise, suppression of ABAT results in depletion of transient lower esophageal sphincter relaxation (TLESR) and acid reflux activity.Treating of GERD is possible means of suppressing ABAT’s physiology.<ref name=":1" /> | |||
== ABAT Deficiency == | |||
ABAT defect is uncommon disorder. The signs and symptoms of this deficiency were observed from a Dutch family, two of the siblings, and a 6 month pediatric Japanese. These patients have same signs and symptoms that were observed. This include low muscle tone or known as [[floppy baby syndrome]], over responsive reflexes and developmental delay.<ref name=":4">{{cite journal | vauthors = Nagappa M, Bindu PS, Chiplunkar S, Govindaraj P, Narayanappa G, Krishnan A, Bharath MM, Swaminathan A, Saini J, Arvinda HR, Sinha S, Mathuranath PS, Taly AB | title = Hypersomnolence-hyperkinetic movement disorder in a child with compound heterozygous mutation in 4-aminobutyrate aminotransferase (ABAT) gene | journal = Brain & Development | volume = 39 | issue = 2 | pages = 161–165 | date = February 2017 | pmid = 27596361 | doi = 10.1016/j.braindev.2016.08.005 }}</ref> The ABAT deficiency phenotype includes psychomotor retardation, [[hypotonia]], [[hyperreflexia]], lethargy, refractory [[seizure]]s, and [[EEG]] abnormalities. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene.<ref name="entrez" /> Abnormal [[4-aminobutyrate transaminase|GABA-transaminaze]] enzyme results in encephalopathy which is observed in pediatric patients and this deficiency have life expectancy of less than 2 years and some survived more than the given life expectancy.Abnormal protein that is being set free from uncontrolled amount of GABA will affect the growth of individual (growth hormone).<ref name=":0" /> | |||
Decrease level of GABA concentration results in convulsion.<ref name=":5">{{cite journal | vauthors = Ramirez AK, Lynes MD, Shamsi F, Xue R, Tseng YH, Kahn CR, Kasif S, Dreyfuss JM | title = Integrating Extracellular Flux Measurements and Genome-Scale Modeling Reveals Differences between Brown and White Adipocytes | journal = Cell Reports | volume = 21 | issue = 11 | pages = 3040–3048 | date = December 2017 | pmid = 29241534 | pmc = 5841536 | doi = 10.1016/j.celrep.2017.11.065 }}</ref> | |||
== Medicine == | |||
[[Vigabatrin]] is a drug that is irreparably suppresses GABA transaminase that causes increased amount of GABA in the brain.<ref>{{cite journal | vauthors = Brecht EJ, Barsz K, Gross B, Walton JP | title = Increasing GABA reverses age-related alterations in excitatory receptive fields and intensity coding of auditory midbrain neurons in aged mice | journal = Neurobiology of Aging | volume = 56 | pages = 87–99 | date = August 2017 | pmid = 28532644 | doi = 10.1016/j.neurobiolaging.2017.04.003 }}</ref> | |||
== Discovery == | |||
In a recent study, it was found out that the increase amount of GABA will stop the consequences of drug addiction.<ref>{{cite journal | vauthors = Choi S, Storici P, Schirmer T, Silverman RB | title = Design of a conformationally restricted analogue of the antiepilepsy drug Vigabatrin that directs its mechanism of inactivation of gamma-aminobutyric acid aminotransferase | journal = Journal of the American Chemical Society | volume = 124 | issue = 8 | pages = 1620–4 | date = February 2002 | pmid = 11853435 | doi = 10.1021/ja011968d }}</ref> The suppression of ABAT which causing the amount of GABA to increase has a connection to children with those suffer from movement disability.<ref name=":4" /> This gene is also link as one genetic cause of [[Gastroesophageal reflux disease|GERD]].<ref name=":1" /> | |||
ABAT has been proved that it is important in mitochondrial nucleoside.<ref name=":5" /> | |||
== References == | == References == | ||
{{reflist}} | {{reflist}} | ||
==External links== | == External links == | ||
* {{UCSC gene info|ABAT}} | * {{UCSC gene info|ABAT}} | ||
== Further reading == | == Further reading == | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
* {{cite journal | vauthors = Medina-Kauwe LK, Tobin AJ, De Meirleir L, Jaeken J, Jakobs C, Nyhan WL, Gibson KM | title = 4-Aminobutyrate aminotransferase (GABA-transaminase) deficiency | journal = Journal of Inherited Metabolic Disease | volume = 22 | issue = 4 | date = | * {{cite journal | vauthors = Medina-Kauwe LK, Tobin AJ, De Meirleir L, Jaeken J, Jakobs C, Nyhan WL, Gibson KM | title = 4-Aminobutyrate aminotransferase (GABA-transaminase) deficiency | journal = Journal of Inherited Metabolic Disease | volume = 22 | issue = 4 | pages = 414–27 | date = June 1999 | pmid = 10407778 | doi = 10.1023/A:1005500122231 }} | ||
* {{cite journal | vauthors = Jeremiah S, Povey S | title = The biochemical genetics of human gamma-aminobutyric acid transaminase | journal = Annals of Human Genetics | volume = 45 | issue = | * {{cite journal | vauthors = Jeremiah S, Povey S | title = The biochemical genetics of human gamma-aminobutyric acid transaminase | journal = Annals of Human Genetics | volume = 45 | issue = 3 | pages = 231–6 | date = July 1981 | pmid = 7305280 | doi = 10.1111/j.1469-1809.1981.tb00334.x }} | ||
* {{cite journal | vauthors = De Biase D, Barra D, Simmaco M, John RA, Bossa F | title = Primary structure and tissue distribution of human 4-aminobutyrate aminotransferase | journal = European Journal of Biochemistry | * {{cite journal | vauthors = De Biase D, Barra D, Simmaco M, John RA, Bossa F | title = Primary structure and tissue distribution of human 4-aminobutyrate aminotransferase | journal = European Journal of Biochemistry | volume = 227 | issue = 1-2 | pages = 476–80 | date = January 1995 | pmid = 7851425 | doi = 10.1111/j.1432-1033.1995.tb20412.x }} | ||
* {{cite journal | vauthors = Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C, Banerjee-Basu S, Baron-Cohen S | title = Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome | journal = Autism Research | volume = 2 | issue = 3 | date = | * {{cite journal | vauthors = Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C, Banerjee-Basu S, Baron-Cohen S | title = Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome | journal = Autism Research | volume = 2 | issue = 3 | pages = 157–77 | date = June 2009 | pmid = 19598235 | doi = 10.1002/aur.80 }} | ||
* {{cite journal | vauthors = Jirholt J, Asling B, Hammond P, Davidson G, Knutsson M, Walentinsson A, Jensen JM, Lehmann A, Agreus L, Lagerström-Fermer M | title = 4-aminobutyrate aminotransferase (ABAT): genetic and pharmacological evidence for an involvement in gastro esophageal reflux disease | journal = PLOS | * {{cite journal | vauthors = Jirholt J, Asling B, Hammond P, Davidson G, Knutsson M, Walentinsson A, Jensen JM, Lehmann A, Agreus L, Lagerström-Fermer M | title = 4-aminobutyrate aminotransferase (ABAT): genetic and pharmacological evidence for an involvement in gastro esophageal reflux disease | journal = PLOS One | volume = 6 | issue = 4 | pages = e19095 | date = April 2011 | pmid = 21552517 | pmc = 3084265 | doi = 10.1371/journal.pone.0019095 }} | ||
* {{cite journal | vauthors = Rainesalo S, Saransaari P, Peltola J, Keränen T | title = Uptake of GABA and activity of GABA-transaminase in platelets from epileptic patients | journal = Epilepsy Research | volume = 53 | issue = 3 | date = | * {{cite journal | vauthors = Rainesalo S, Saransaari P, Peltola J, Keränen T | title = Uptake of GABA and activity of GABA-transaminase in platelets from epileptic patients | journal = Epilepsy Research | volume = 53 | issue = 3 | pages = 233–9 | date = March 2003 | pmid = 12694932 | doi = 10.1016/s0920-1211(03)00030-5 }} | ||
* {{cite journal | vauthors = Jaeken J, Casaer P, de Cock P, Corbeel L, Eeckels R, Eggermont E, Schechter PJ, Brucher JM | title = Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism | journal = Neuropediatrics | volume = 15 | issue = 3 | pages = 165–9 | date = August 1984 | pmid = 6148708 | doi = 10.1055/s-2008-1052362 }} | |||
* {{cite journal | vauthors = Jaeken J, Casaer P, de Cock P, Corbeel L, Eeckels R, Eggermont E, Schechter PJ, Brucher JM | title = Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism | journal = Neuropediatrics | volume = 15 | issue = 3 | date = | * {{cite journal | vauthors = Hearl WG, Churchich JE | title = Interactions between 4-aminobutyrate aminotransferase and succinic semialdehyde dehydrogenase, two mitochondrial enzymes | journal = The Journal of Biological Chemistry | volume = 259 | issue = 18 | pages = 11459–63 | date = September 1984 | pmid = 6470007 }} | ||
* {{cite journal | vauthors = Hearl WG, Churchich JE | title = Interactions between 4-aminobutyrate aminotransferase and succinic semialdehyde dehydrogenase, two mitochondrial enzymes | journal = The Journal of Biological Chemistry | volume = 259 | issue = 18 | date = | |||
{{refend}} | {{refend}} | ||
{{NLM content}} | {{NLM content}} | ||
Revision as of 18:27, 27 November 2018
| VALUE_ERROR (nil) | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Aliases | |||||||
| External IDs | GeneCards: [1] | ||||||
| Orthologs | |||||||
| Species | Human | Mouse | |||||
| Entrez |
|
| |||||
| Ensembl |
|
| |||||
| UniProt |
|
| |||||
| RefSeq (mRNA) |
|
| |||||
| RefSeq (protein) |
|
| |||||
| Location (UCSC) | n/a | n/a | |||||
| PubMed search | n/a | n/a | |||||
| Wikidata | |||||||
| |||||||
4-Aminobutyrate aminotransferase is a protein that in humans is encoded by the ABAT gene.[1] This gene is located in chromosome 16 at position of 13.2.[2] This gene has also different name, to give some are GABA, GABAT, 4-aminobutyrate transaminase, NPD009 and etc.[2] This gene is mainly and abundant located in neuronal tissues.[3] 4-Aminobutyrate aminotransferase belongs to group of pyridoxal 5-phosphate-dependent enzyme which activates a large portion giving reaction to amino acids.[4] ABAT is made up of two monomers of enzymes where each subunit has a molecular weight of 50kDa.[5] It is identified that almost tierce of human synapses have GABA.[2] GABA is a neurotransmitter that has different roles in different regiions of the central and peripheral nervous systems. It can be found also in some tissues that do not have neurons.[2] In addition, GAD and GABA-AT are responsible in regulating the concentration of GABA.[6]
Characteristic
GABA’s feature is that it does not fluorescent nor electroactive which is why it is hard to determine the reaction of enzymes because no peroxidase and dehydrogenase was identified.[7] One characteristic of GABA is having low lipophilic which results in the difficulty to cross the blood brain barrier. A lot of researchers have been trying to discover molecules that have a property of high lipophilicity.[6] The quantification of GABA concentration during cell activity needs to have high spatial and temporal resolution. As before, high performance liquid chromatography (HPLC) was used in quantifying GABA concentration levels. In present time, GABA is now analyze, measured in small volume with a short period of time with the use of electrochemiluminescence.[7] GABA acts as a tropic factor which then affects some cell activity such as rapid cell reproduction, cell death and differentiation. Intracellular communication is also one of the many functions of GABA outside the nervous system.[7]
Function
4-Aminobutyrate aminotransferase (ABAT) is responsible for catabolism of gamma-aminobutyric acid (GABA), an important, mostly inhibitory neurotransmitter in the central nervous system, into succinic semialdehyde. The active enzyme is a homodimer of 50-kD subunits complexed to pyridoxal-5-phosphate. The protein sequence is over 95% similar to the pig protein. ABAT in liver and brain is controlled by 2 codominant alleles with a frequency in a Caucasian population of 0.56 and 0.44.[1] GABA acts as a tropic factor which then affects some cell activity such as rapid cell reproduction, cell death and differentiation. Intracellular communication is also one of the many functions of GABA outside the nervous system.[7] GABA-transaminaze enzyme production was made of ABAT gene command. The main function of ABAT acts as inhibition (neurotransmitter), where it prevents overloading activity of the brain from large amount of signals.[2]
ABAT activates the beginning of deterioration of GABA. Likewise, suppression of ABAT results in depletion of transient lower esophageal sphincter relaxation (TLESR) and acid reflux activity.Treating of GERD is possible means of suppressing ABAT’s physiology.[3]
ABAT Deficiency
ABAT defect is uncommon disorder. The signs and symptoms of this deficiency were observed from a Dutch family, two of the siblings, and a 6 month pediatric Japanese. These patients have same signs and symptoms that were observed. This include low muscle tone or known as floppy baby syndrome, over responsive reflexes and developmental delay.[8] The ABAT deficiency phenotype includes psychomotor retardation, hypotonia, hyperreflexia, lethargy, refractory seizures, and EEG abnormalities. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene.[1] Abnormal GABA-transaminaze enzyme results in encephalopathy which is observed in pediatric patients and this deficiency have life expectancy of less than 2 years and some survived more than the given life expectancy.Abnormal protein that is being set free from uncontrolled amount of GABA will affect the growth of individual (growth hormone).[2]
Decrease level of GABA concentration results in convulsion.[9]
Medicine
Vigabatrin is a drug that is irreparably suppresses GABA transaminase that causes increased amount of GABA in the brain.[10]
Discovery
In a recent study, it was found out that the increase amount of GABA will stop the consequences of drug addiction.[11] The suppression of ABAT which causing the amount of GABA to increase has a connection to children with those suffer from movement disability.[8] This gene is also link as one genetic cause of GERD.[3]
ABAT has been proved that it is important in mitochondrial nucleoside.[9]
References
- ↑ 1.0 1.1 1.2 "Entrez Gene: 4-aminobutyrate aminotransferase".
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H (2002). "GABA and GABA receptors in the central nervous system and other organs". International Review of Cytology. Elsevier. 213: 1–47. doi:10.1016/s0074-7696(02)13011-7. ISBN 9780123646170. PMID 11837891.
- ↑ 3.0 3.1 3.2 Jirholt J, Asling B, Hammond P, Davidson G, Knutsson M, Walentinsson A, Jensen JM, Lehmann A, Agreus L, Lagerström-Fermer M (April 2011). "4-aminobutyrate aminotransferase (ABAT): genetic and pharmacological evidence for an involvement in gastro esophageal reflux disease". PLOS One. 6 (4): e19095. doi:10.1371/journal.pone.0019095. PMC 3084265. PMID 21552517.
- ↑ Markova M, Peneff C, Hewlins MJ, Schirmer T, John RA (October 2005). "Determinants of substrate specificity in omega-aminotransferases". The Journal of Biological Chemistry. 280 (43): 36409–16. doi:10.1074/jbc.m506977200. PMID 16096275.
- ↑ Churchich JE (September 1982). "4-Aminobutyrate aminotransferase. Different susceptibility to inhibitors, microenvironment of the cofactor binding site and distance of the catalytic sites". European Journal of Biochemistry. 126 (3): 507–11. PMID 7140743.
- ↑ 6.0 6.1 Tovar-Gudiño E, Guevara-Salazar JA, Bahena-Herrera JR, Trujillo-Ferrara JG, Martínez-Campos Z, Razo-Hernández RS, Santiago Á, Pastor N, Fernández-Zertuche M (May 2018). "Pseudomonas fluorescens and In Silico Molecular Modeling". Molecules. 23 (5): 1128. doi:10.3390/molecules23051128. PMID 29747438.
- ↑ 7.0 7.1 7.2 7.3 Salazar-Sánchez JC, Morales-Villagrán A, López-Pérez SJ, Pardo-Peña K, Villalpando-Vargas F, Medina-Ceja L (June 2018). "γ-Aminobutyric acid quantification in small volume biological samples through enzymatically induced electrochemiluminescence". Luminescence. 33 (4): 722–730. doi:10.1002/bio.3469. PMID 29653023.
- ↑ 8.0 8.1 Nagappa M, Bindu PS, Chiplunkar S, Govindaraj P, Narayanappa G, Krishnan A, Bharath MM, Swaminathan A, Saini J, Arvinda HR, Sinha S, Mathuranath PS, Taly AB (February 2017). "Hypersomnolence-hyperkinetic movement disorder in a child with compound heterozygous mutation in 4-aminobutyrate aminotransferase (ABAT) gene". Brain & Development. 39 (2): 161–165. doi:10.1016/j.braindev.2016.08.005. PMID 27596361.
- ↑ 9.0 9.1 Ramirez AK, Lynes MD, Shamsi F, Xue R, Tseng YH, Kahn CR, Kasif S, Dreyfuss JM (December 2017). "Integrating Extracellular Flux Measurements and Genome-Scale Modeling Reveals Differences between Brown and White Adipocytes". Cell Reports. 21 (11): 3040–3048. doi:10.1016/j.celrep.2017.11.065. PMC 5841536. PMID 29241534.
- ↑ Brecht EJ, Barsz K, Gross B, Walton JP (August 2017). "Increasing GABA reverses age-related alterations in excitatory receptive fields and intensity coding of auditory midbrain neurons in aged mice". Neurobiology of Aging. 56: 87–99. doi:10.1016/j.neurobiolaging.2017.04.003. PMID 28532644.
- ↑ Choi S, Storici P, Schirmer T, Silverman RB (February 2002). "Design of a conformationally restricted analogue of the antiepilepsy drug Vigabatrin that directs its mechanism of inactivation of gamma-aminobutyric acid aminotransferase". Journal of the American Chemical Society. 124 (8): 1620–4. doi:10.1021/ja011968d. PMID 11853435.
External links
- Human ABAT genome location and ABAT gene details page in the UCSC Genome Browser.
Further reading
- Medina-Kauwe LK, Tobin AJ, De Meirleir L, Jaeken J, Jakobs C, Nyhan WL, Gibson KM (June 1999). "4-Aminobutyrate aminotransferase (GABA-transaminase) deficiency". Journal of Inherited Metabolic Disease. 22 (4): 414–27. doi:10.1023/A:1005500122231. PMID 10407778.
- Jeremiah S, Povey S (July 1981). "The biochemical genetics of human gamma-aminobutyric acid transaminase". Annals of Human Genetics. 45 (3): 231–6. doi:10.1111/j.1469-1809.1981.tb00334.x. PMID 7305280.
- De Biase D, Barra D, Simmaco M, John RA, Bossa F (January 1995). "Primary structure and tissue distribution of human 4-aminobutyrate aminotransferase". European Journal of Biochemistry. 227 (1–2): 476–80. doi:10.1111/j.1432-1033.1995.tb20412.x. PMID 7851425.
- Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C, Banerjee-Basu S, Baron-Cohen S (June 2009). "Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome". Autism Research. 2 (3): 157–77. doi:10.1002/aur.80. PMID 19598235.
- Jirholt J, Asling B, Hammond P, Davidson G, Knutsson M, Walentinsson A, Jensen JM, Lehmann A, Agreus L, Lagerström-Fermer M (April 2011). "4-aminobutyrate aminotransferase (ABAT): genetic and pharmacological evidence for an involvement in gastro esophageal reflux disease". PLOS One. 6 (4): e19095. doi:10.1371/journal.pone.0019095. PMC 3084265. PMID 21552517.
- Rainesalo S, Saransaari P, Peltola J, Keränen T (March 2003). "Uptake of GABA and activity of GABA-transaminase in platelets from epileptic patients". Epilepsy Research. 53 (3): 233–9. doi:10.1016/s0920-1211(03)00030-5. PMID 12694932.
- Jaeken J, Casaer P, de Cock P, Corbeel L, Eeckels R, Eggermont E, Schechter PJ, Brucher JM (August 1984). "Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism". Neuropediatrics. 15 (3): 165–9. doi:10.1055/s-2008-1052362. PMID 6148708.
- Hearl WG, Churchich JE (September 1984). "Interactions between 4-aminobutyrate aminotransferase and succinic semialdehyde dehydrogenase, two mitochondrial enzymes". The Journal of Biological Chemistry. 259 (18): 11459–63. PMID 6470007.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.